Sabra Health Care REIT Inc expected to post earnings of 14 cents a share - Earnings Preview

Sabra Health Care REIT

07/05/2024 03:05

* Sabra Health Care REIT Inc  SBRA.OQ   SBRA.O  is expected
to show a fall in quarterly revenue when it reports  results on
May 8 for the period ending March 31 2024
    * The Irvine California-based  company is expected to report
a
0.9% decrease in revenue to $159.881 million from $161.32
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Sabra Health Care REIT
Inc is
for earnings of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $16.00​, above​ its last closing price of $14.61.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.33        0.33       0.32      Missed  -3.2
 Sep. 30 2023  0.33        0.33       0.33      Met     -0.8
 Jun. 30 2023  0.33        0.33       0.33      Met     -1.3​
 Mar. 31 2023  0.34        0.34       0.33      Missed  -4
 ​​Dec.        0.35        0.36       0.37      Beat    4.1
 31 2022                                                
 Sep. 30 2022  0.37        0.37       0.36      Missed  -3.2​
 Jun. 30 2022  0.38        0.38       0.39      Beat    3.6
 Mar. 31 2022  0.38        0.38       0.38      Met     -0.7
 This summary was machine generated May 7 at 02:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)